Drugs / Acetic Acid
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | VOSOL | — | 1960-05-17 | fda.gov ↗ |
Trials 5 · a red edge is where a trial was stopped
19591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06356480 | Oct 2023 → Apr 2024 | — | Dr. Muhammad Naeem | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02614703 | Mar 2017 → Jul 2018 | Barrett esophagus | DHR Health Institute for Research and Development | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06297967 | Apr 2025 → Mar 2027 expected | chronic ulcer of skin | Consorci Sanitari de l'Alt Penedès i Garraf | Recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02407392 | Jul 2015 → Jan 2017 | Barrett esophagus | Portsmouth Hospitals NHS Trust | Completed | No outcome recorded |
| — | NCT02231385 | Sep 2014 → Jan 2015 | colorectal adenoma, colorectal cancer, tubular adenoma | Istituto Clinico Humanitas | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02420665 Background | Sep 2015 → May 2021 | cervical cancer | M.D. Anderson Cancer Center | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT02806115 Background | Jun → Aug 2016 | gastric intestinal metaplasia | Shandong University | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05617872 Comparator | Dec 2022 → May 2025 | malignant pancreatic neoplasm | Peking Union Medical College Hospital | Completed | No outcome recorded |
| — | NCT02335372 Background | Jun 2013 → Oct 2021 | cervical cancer | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acetic Acid | “Inject 20ml vinegar (5% acetic acid solution) into duodenum and collect the pancreatic juice for 15 minutes via EUS, changing the collection bottle every 5 minutes.” NCT05617872 ↗ |
| Modality | Diagnostic / imaging agent | “The purpose of this study is to compare the additional diagnostic yield obtained by using the acetic acid as vital substance to improve the detection of serrated lesions at colonoscopy.” NCT02231385 ↗ |
| Route | Topical | “acetic acid 2% will be sprayed” NCT02231385 ↗ |